SVA : Summary for Sinovac Biotech, Ltd. - Ordinar - Yahoo Finance

U.S. Markets closed

Sinovac Biotech Ltd. (SVA)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.10-0.01 (-0.16%)
At close: 4:00 PM EST
People also watch:
CAASCBAKCNTFJRJCACTS
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close6.11
Open6.10
Bid5.60 x 10000
Ask6.60 x 100
Day's Range6.05 - 6.12
52 Week Range4.38 - 7.16
Volume69,385
Avg. Volume51,731
Market Cap347.48M
Beta0.45
PE Ratio (TTM)-75.31
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube2 days ago

    ETFs with exposure to Sinovac Biotech Ltd. : December 1, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Sinovac Biotech Ltd. Here are 5 ETFs with the largest exposure to SVA-US. Comparing the performance and risk of Sinovac Biotech Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Sinovac Biotech Ltd. :SVA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 30, 2016
    Capital Cube3 days ago

    Sinovac Biotech Ltd. :SVA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 30, 2016

    Categories: Yahoo Finance Get free summary analysis Sinovac Biotech Ltd. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Sinovac Biotech Ltd. – Newlink Genetics Corporation, Dynavax Technologies Corporation, GlaxoSmithKline plc Sponsored ADR, SIGA Technologies Inc, Novartis AG Sponsored ADR, Merck & Co., Inc., Astrazeneca PLC Sponsored ... Read more (Read more...)

  • Associated Press6 days ago

    Sinovac posts 3Q profit

    The Beijing-based company said it had profit of 6 cents per share. The biopharmaceutical company posted revenue of $28.7 million in the period. Sinovac shares have risen 8 percent since the beginning of ...